(Q43423723)

23 November 2017

title

Multi-center randomized controlled study to establish the standard third-line regimen for Helicobacter pylori eradication in Japan (English)

1 reference

23 November 2017

1 reference

1

Kazunari Murakami

1 reference

23 November 2017

Takahisa Furuta

2

1 reference

23 November 2017

Takashi Ando

3

1 reference

23 November 2017

Takeshi Nakajima

4

1 reference

23 November 2017

Yoshikatsu Inui

5

1 reference

23 November 2017

Tadayuki Oshima

6

1 reference

23 November 2017

Toshihiko Tomita

7

1 reference

23 November 2017

Katsuhiro Mabe

8

1 reference

23 November 2017

Makoto Sasaki

9

1 reference

23 November 2017

Takanori Suganuma

10

1 reference

23 November 2017

Hideyuki Nomura

11

1 reference

23 November 2017

Kiichi Satoh

12

1 reference

23 November 2017

Shinichiro Hori

13

1 reference

23 November 2017

Syuuji Inoue

14

1 reference

23 November 2017

Takeshi Tomokane

15

1 reference

23 November 2017

Mineo Kudo

16

1 reference

23 November 2017

Tomoki Inaba

17

1 reference

23 November 2017

Susumu Take

18

1 reference

23 November 2017

Toshifumi Ohkusa

19

1 reference

23 November 2017

Shojiro Yamamoto

20

1 reference

23 November 2017

Shigeaki Mizuno

21

1 reference

23 November 2017

Toshiro Kamoshida

22

1 reference

23 November 2017

Kenji Amagai

23

1 reference

23 November 2017

Junichi Iwamoto

24

1 reference

23 November 2017

Jun Miwa

25

1 reference

23 November 2017

Masaaki Kodama

26

1 reference

23 November 2017

Tadayoshi Okimoto

27

1 reference

23 November 2017

Mototsugu Kato

28

1 reference

23 November 2017

Masahiro Asaka

29

1 reference

23 November 2017

Japan GAST Study Group

30

1 reference

23 November 2017

publication date

11 January 2013

1 reference

23 November 2017

number of pages

8

1 reference

Journal of Gastroenterology

inferred from page(s)

published in

1 reference

23 November 2017

volume

48

1 reference

23 November 2017

issue

10

1 reference

23 November 2017

page(s)

1128-1135

1 reference

Helicobacter pylori infection and the development of gastric cancer

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0731-8

Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0731-8

Susceptibilities to clarithromycin, amoxycillin and metronidazole of Helicobacter pylori isolates from the antrum and corpus in Tokyo, Japan, 1995-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0731-8

Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0731-8

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0731-8

Efficacy of Helicobacter pylori eradication therapies: a single centre observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0731-8

Third-line rescue therapy with levofloxacin after two H. pylori treatment failures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0731-8

Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0731-8

A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0731-8

Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0731-8

Sitafloxacin resistance in Helicobacter pylori isolates and sitafloxacin-based triple therapy as a third-line regimen in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0731-8

Efficacy of sitafloxacin-based rescue therapy for Helicobacter pylori after failures of first- and second-line therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0731-8

Sitafloxacin activity against Helicobacter pylori isolates, including those with gyrA mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0731-8

Sitafloxacin and garenoxacin may overcome the antibiotic resistance of Helicobacter pylori with gyrA mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0731-8

Helicobacter pylori Eradication by Sitafloxacin-Lansoprazole Combination and Sitafloxacin Pharmacokinetics in Mongolian Gerbils and ItsIn VitroActivity and Resistance Development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0731-8

Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area

21 January 2018

1 reference

12 December 2020

Effect of lansoprazole on intragastric pH. Comparison between morning and evening dosing

1 reference

12 December 2020

Third line treatment for Helicobacter pylori: a prospective, culture-guided study in peptic ulcer patients

1 reference

12 December 2020

Susceptibility of Helicobacter pylori to mupirocin, oxazolidinones, quinupristin/dalfopristin and new quinolones

1 reference

12 December 2020

Comparison of the efficacy of 400mg and 800mg of clarithromycin used with lansoprazole and amoxicillin in eradication regimens for Helicobacter pylori infection in a Japanese population

1 reference

12 December 2020

10.1007/S00535-012-0731-8

Identifiers

DOI

1 reference

23 November 2017

1 reference